Skip to main content

Ascendis Pharma ADR(ASND-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Ascendis Pharma ADR

TUBORG BOULEVARD 12
HELLERUP G7 2900 DNK
P: 45-7022-2244
http://www.ascendispharma.com

Profile

Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology, central nervous system disorders, infectious diseases and diabetes. Its technology includes TransCon which develop prodrug therapies. Ascendis Pharma A/S is based in Denmark.

Key Executives

NameTitle
Michael Wolff JensenChief Legal Officer/Executive VP
Jan Moller MikkelsenCEO/Co-Founder/Director/President
Lotte SonderbjergChief Administrative Officer/Executive VP
Flemming Steen JensenExecutive VP, Divisional
Kennett SprogoeExecutive VP/Other Corporate Officer
Scott T SmithCFO/Executive VP
Stina SingelExecutive VP/Other Corporate Officer
Aimee ShuChief Medical Officer/Executive VP
Jay Donovan WuExecutive VP/President, Geographical
Mads BodenhoffChief Accounting Officer/Other Corporate Officer/Senior VP
Jethro EkutaOther Executive Officer
Sherrie GlassOther Executive Officer

More from The Globe

The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
Bullish on Archer-Daniels-Midland Co.
Monica Rizk
Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
number cruncher
Eight telecom stocks to watch during volatile times
For Number Cruncher column in Globe Investor/ROB only.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.